Aesthetics, built from science

Christelle Huguet, EVP Head of R&D

Ipsen is not new to aesthetics. For more than three decades, we have been advancing neuroscience innovations across therapeutic and aesthetic indications, building deep expertise in complex biologics, rigorous clinical development and high‑quality manufacturing. Our approved medicines are approved for aesthetic use in more than 80 countries worldwide, through our direct presence and trusted partners.

This heritage matters because the field of aesthetics is evolving, and its future will be shaped by science and data.

At Ipsen, innovation has always followed understanding. We build on what we know, learn from data and apply the same scientific discipline across therapeutic and aesthetic medicine. That approach has allowed us to translate decades of neuroscience research into solutions designed to meet rising expectations around quality, consistency and clinical robustness.

Today, expectations are changing. Patients, consumers and their treating physicians want treatments grounded in evidence, designed with intention and developed to consistently high standards. That requires more than incremental iteration, it demands deep biological insight, rigorous development pathways and confidence in the science behind every decision.

This conviction is reflected in how we invest. Today, 15% of Ipsen’s total R&D investment is dedicated to aesthetic indications.* We are advancing multiple Phase II and Phase III studies across aesthetic uses, reinforcing our vision to remain the engine of meaningful innovation in aesthetics.

Science‑led innovation also depends on the ability to translate discovery into reality. Ipsen’s manufacturing facilities are equipped with capabilities designed for the next generation of complex biologic treatments. They reflect long‑term investment in quality, reproducibility and manufacturing excellence – capabilities that matter when science moves from hypothesis to patient.

Aesthetics is advancing rapidly. But progress that lasts is built on evidence, experience and execution.

At Ipsen, we continue to shape the future of aesthetics through evidence based research, data driven decisions and building on decades of neuroscience expertise to deliver innovation.

*Reflects Ipsen R&D spend projected for 2026. Internal figure, February 2026.